Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3

Asthma Clinical Trial

Official title:

Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01966068
• Other study ID #: 13-010285
• Status: Active, not recruiting
• Phase: N/A
• First received: October 11, 2013
• Last updated: March 9, 2016
• Start date: October 2013
• Est. completion date: December 2016

Study information

• Verified date: March 2016
• Source: Children's Hospital of Philadelphia
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This study uses a newly published, evidence-based conceptual model to study the determinants of implementation success, implementation outcomes, and health care outcomes resulting from implementing an asthma portal, MyAsthma, in the national, Agency for Health Care Research and Quality(AHRQ)-funded, Center for Pediatric Practice Research and Learning. Technically, the portal will be implemented with 2 innovative approaches that facilitate rapid cycle evaluation in multiple Electronic Health Records (EHRs). Although many patient portals are simple vehicles for transferring information about upcoming appointments, test results or laboratory findings, the asthma portal in this project extends this basic functionality to provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' preferences and goals. Because asthma is an AHRQ priority condition which addresses three AHRQ priority criteria (children, low income, and special health care needs), our study will use this population to focus on stage 3 Meaningful Use (MU3) objectives. It is the hope that by conducting this study, translational knowledge will be gained to make recommendations for practice implementation and actionable policy statements.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 294
• Est. completion date: December 2016
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 6 Years to 12 Years

Eligibility

Inclusion Criteria:

• Child has a diagnosis of asthma on his/her problem list

• Aged 6-12

Exclusion Criteria:

• No visit with in the last 12 months

• Parent or guardian does not speak or read English

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Asthma

Intervention

Other:
• MyAsthma Web Portal

Locations

Country	Name	City	State
United States	PROS	Elk Grove Village	Illinois
United States	PeRC	Philadelphia	Pennsylvania

Sponsors (4)

Lead Sponsor	Collaborator
Children's Hospital of Philadelphia	Agency for Healthcare Research and Quality (AHRQ), American Academy of Pediatrics, DARTNet Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Use of the MyAsthma Portal Survey	We will evaluate adoption of the MyAsthma portal by determining which subjects completed the MyAsthma Portal Survey at least once during the study period. We will also measure sustained use of the portal, defined as completion of the MyAsthma Portal Survey more than once during the study period.	Each subject will contribute data up to 3 times over a 3 month period	No
Secondary	Asthma management	We will measure those making an asthma office visit in the two weeks following completion of a MyAsthma portal survey. We will also measure the number of subjects that refill their asthma medication or make a medication change in the two weeks following completion of a MyAsthma portal survey.	2 weeks following completion of a MyAsthma portal survey	No